Log in or Sign up for Free to view tailored content for your specialty!
Kidney Care Community News
Study finds room for improvement in care coordination between dialysis centers, hospitals
Although researchers from Emory University found communication between hospitals and dialysis facilities to be “suboptimal,” patients viewed overall care coordination favorably, according to a study that included a one-time patient survey.
‘Green’ nephrology can reduce the environment footprint of the industry
The kidney community needs to recognize the impact of dialysis on the environment, particularly its dependence on Earth’s limited fresh water, a speaker at the virtual Innovations in Dialysis: Expediting Advances Symposium said.
Log in or Sign up for Free to view tailored content for your specialty!
Congress remains supportive of funding innovation in kidney care
Congress continues to support funding for developing smarter, more efficient and patient-friendly dialysis machines that simplify the treatment process, a speaker said at the virtual Innovations in Dialysis: Expediting Advances Symposium.
Fresenius Medical Care AG increases its investment in Humacyte
Fresenius Medical Care AG has invested an additional $25 million in clinical-stage biotechnology platform company Humacyte Inc., following an initial investment of $150 million made in 2018.
FDA grants breakthrough device designation to digital fluid management tool
The FDA granted breakthrough device designation to ImpediMed Limited’s digital health platform for a proposed indication in kidney failure; the device uses bioimpedance spectroscopy to assess fluid status in patients on dialysis.
Underrepresented groups with ESKD twice as likely to die from COVID-19 vs white patients
A study of patients with end-stage kidney disease and COVID-19 revealed those who were from historically underrepresented groups had more than double the mortality rate of their white counterparts.
Speaker: Patient input critical for ensuring equitable access to new dialysis technologies
Holding patient insight as valuable, and thus expanding ways patients can participate in all stages of product development, is essential to ensuring equitable access to emerging dialysis technologies, an expert in patient advocacy said.
FDA approves Korsuva as treatment for pruritus in patients on hemodialysis
Vifor Pharma and Cara Therapeutics announced the FDA has approved Korsuva for the treatment of moderate to severe pruritus in patients on hemodialysis.
FDA approves Korsuva as treatment for pruritus in patients on hemodialysis
Vifor Pharma and Cara Therapeutics announced the FDA has approved Korsuva for the treatment of moderate to severe pruritus in patients on hemodialysis.
Artificial intelligence-focused company expands kidney care platform with anemia care tool
Dosis, described in a press release as “a market leader in artificial intelligence-powered precision dosing,” has developed a new tool to personalize anemia management in chronic kidney disease.